• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by CM Life Sciences, Inc.

    8/2/21 12:56:36 PM ET
    $CMLF
    Business Services
    Finance
    Get the next $CMLF alert in real time by email
    SC 13G 1 e620834_sc13g-sema4.htm

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (Amendment No. )*

     

    Sema4 Holding Corp.

    (Name of Issuer)

     

    Class A Common Stock

    (Title of Class of Securities)

     

    81663L101 

    (CUSIP Number)

     

    July 22, 2021

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

      

    ☐  Rule 13d-1(b)

     

    ☒  Rule 13d-1(c)

     

    ☐  Rule 13d-1(d)

     

    (Page 1 of 11 Pages)

     

    ----------

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

      

    CUSIP No. 81663L101 13G Page 2 of 11

     

    1.

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Deerfield Mgmt, L.P.

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     

    (a) ☐

    (b) ☒

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

     
    6.

    SHARED VOTING POWER

     

    6,924,244 (1)

     

    7.

     

    SOLE DISPOSITIVE POWER

     

    0

     

    8.

     

    SHARED DISPOSITIVE POWER

     

    6,924,244 (1)

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    6,924,244 (1)

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.88%

    12.

    TYPE OF REPORTING PERSON*

     

    PN

    __________________

    (1) Comprised of 6,924,244 shares of Class A Common Stock held by Deerfield Partners, L.P., of which Deerfield Mgmt, L.P. is the general partner.

     

    CUSIP No. 81663L101 13G Page 3 of 11

     

    1.

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Deerfield Management Company, L.P.

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     

    (a) ☐

    (b) ☒

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

     
    6.

    SHARED VOTING POWER

     

    13,848,488 (2)

     

    7.

     

    SOLE DISPOSITIVE POWER

     

    0

     

    8.

     

    SHARED DISPOSITIVE POWER

     

    13,848,488 (2)

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    13,848,488 (2)

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    5.77%

    12.

    TYPE OF REPORTING PERSON*

     

    PN

    _________________

    (2) Comprised of an aggregate of 13,848,488 shares of Class A Common Stock held by Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P., of which Deerfield Management Company, L.P. is the investment advisor.

      

    CUSIP No. 81663L101 13G Page 4 of 11

     

    1.

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Deerfield Mgmt V, L.P.

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     

    (a) ☐

    (b) ☒

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

     
    6.

    SHARED VOTING POWER

     

    6,924,244 (3)

     

    7.

     

    SOLE DISPOSITIVE POWER

     

    0

     

    8.

     

    SHARED DISPOSITIVE POWER

     

    6,924,244 (3)

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    6,924,244 (3)

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.88%

    12.

    TYPE OF REPORTING PERSON*

     

    PN 

     _________________

    (3) Comprised of 6,924,244 shares of Class A Common Stock held by Deerfield Private Design Fund V, L.P., of which Deerfield Mgmt V, L.P. is the general partner.

      

    CUSIP No. 81663L101 13G Page 5 of 11

     

    1.

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Deerfield Partners, L.P.

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     

    (a) ☐

    (b) ☒

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

     
    6.

    SHARED VOTING POWER

     

    6,924,244

     

    7.

     

    SOLE DISPOSITIVE POWER

     

    0

     

    8.

     

    SHARED DISPOSITIVE POWER

     

    6,924,244

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    6,924,244

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.88%

    12.

    TYPE OF REPORTING PERSON*

     

    PN

     

    CUSIP No. 81663L101 13G Page 6 of 11

     

    1.

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Deerfield Private Design Fund V, L.P.

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     

    (a) ☐

    (b) ☒

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

     
    6.

    SHARED VOTING POWER

     

    6,924,244

     

    7.

     

    SOLE DISPOSITIVE POWER

     

    0

     

    8.

     

    SHARED DISPOSITIVE POWER

     

    6,924,244

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    6,924,244

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.88%

    12.

    TYPE OF REPORTING PERSON*

     

    PN

      

    CUSIP No. 81663L101 13G Page 7 of 11

     

    1.

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     

    James E. Flynn

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

     

    (a) ☐

    (b) ☒

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

     
    6.

    SHARED VOTING POWER

     

    13,848,488 (4)

     

    7.

     

    SOLE DISPOSITIVE POWER

     

    0

     

    8.

     

    SHARED DISPOSITIVE POWER

     

    13,848,488 (4)

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    13,848,488 (4)

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    5.77%

    12.

    TYPE OF REPORTING PERSON*

     

    IN

    __________________

    (4) Comprised of an aggregate of 13,848,488 shares of common stock held by Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P.

      

    CUSIP No. 81663L101 13G Page 8 of 11

     

    Item 1(a). Name of Issuer:
       
     

    Sema4 Holding Corp.

       
    Item 1(b). Address of Issuer's Principal Executive Offices:
       
     

    333 Ludlow Street, North Tower, 8th Floor

    Stamford, Connecticut 06902 

       
    Item 2(a). Name of Person Filing:
       
     

    James E. Flynn, Deerfield Mgmt, L.P., Deerfield Mgmt V, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P.

       
    Item 2(b). Address of Principal Business Office, or if None, Residence:
       
     

    James E. Flynn, Deerfield Mgmt, L.P., Deerfield Mgmt V, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P., 345 Park Avenue South, 12th Floor, New York, NY 10010

       
    Item 2(c). Citizenship:
       
     

    Deerfield Mgmt, L.P., Deerfield Mgmt V, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P. - Delaware limited partnerships;

     

    James E. Flynn – United States citizen

       
    Item 2(d). Title of Class of Securities:
       
     

    Class A Common Stock

       
    Item 2(e). CUSIP Number:
       
     

    81663L101

         
    Item 3.

    If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

       
    (a) ☐

    Broker or dealer registered under Section 15 of the Exchange Act.

         
    (b) ☐ Bank as defined in Section 3(a)(6) of the Exchange Act.
         
    (c) ☐

    Insurance company as defined in Section 3(a)(19) of the Exchange Act.

         
    (d) ☐

    Investment company registered under Section 8 of the Investment Company Act.

         
    (e) ☐ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
         
    (f) ☐

    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

         
    (g) ☐

    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

         

    (h)

    ☐

    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

     

    CUSIP No. 81663L101 13G Page 9 of 11

     

     

         
    (i) ☐

    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

         
    (j) ☐ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
         
    (k) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________

     

    Item 4. Ownership.
           

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

           
    (a) Amount beneficially owned**:  
           
     

    Deerfield Mgmt, L.P. - 6,924,244 shares

    Deerfield Mgmt V, L.P. – 6,924,244 shares

    Deerfield Management Company, L.P. - 13,848,488 shares

    Deerfield Partners, L.P. - 6,924,244 shares

    Deerfield Private Design Fund V, L.P. – 6,924,244 shares

    James E. Flynn – 13,848,488 shares

           
    (b) Percent of class**:  
           
     

    Deerfield Mgmt, L.P. – 2.88%

    Deerfield Mgmt V, L.P. – 2.88%

    Deerfield Management Company, L.P. – 5.77%

    Deerfield Partners, L.P. - 2.88%

    Deerfield Private Design Fund V, L.P. – 2.88%

    James E. Flynn – 5.77%

           
    (c) Number of shares as to which such person has**:  
           
      (i) Sole power to vote or to direct the vote: All Reporting Persons - 0
           
      (ii) Shared power to vote or to direct the vote:

    Deerfield Mgmt, L.P. - 6,924,244

    Deerfield Mgmt V, L.P. – 6,924,244

    Deerfield Management Company, L.P. - 13,848,488

    Deerfield Partners, L.P. - 6,924,244

    Deerfield Private Design Fund V, L.P. – 6,924,244

    James E. Flynn – 13,848,488

           
      (iii)

    Sole power to dispose or to direct the disposition of:

    All Reporting Persons - 0
           
      (iv)

    Shared power to dispose or to direct the disposition of:

    Deerfield Mgmt, L.P. - 6,924,244

    Deerfield Mgmt V, L.P. – 6,924,244

    Deerfield Management Company, L.P. - 13,848,488

    Deerfield Partners, L.P. - 6,924,244

    Deerfield Private Design Fund V, L.P. – 6,924,244

    James E. Flynn – 13,848,488

      

    **See footnotes on cover pages which are incorporated by reference herein.

      

    CUSIP No. 81663L101 13G Page 10 of 11

     

    Item 5. Ownership of Five Percent or Less of a Class.
       

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following ☐.

       
       
       
    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
       

    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

       
      N/A
       
    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

       

    If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

       
      N/A
       
    Item 8. Identification and Classification of Members of the Group.
       

    If a group has filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the identity of each member of the group.

       
      See Exhibit B
       
    Item 9. Notice of Dissolution of Group.
       

    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.

       
      N/A
       
    Item 10. Certifications.
       

    "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11."

     

    CUSIP No. 81663L101 13G Page 11 of 11

      

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    DEERFIELD MGMT, L.P.

     

    By: J.E. Flynn Capital, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD MANAGEMENT COMPANY, L.P.

     

    By: Flynn Management LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD MGMT V, L.P.

     

    By: J.E. Flynn Capital V, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD PARTNERS, L.P.

     

    By: Deerfield Mgmt, L.P., General Partner

     

    By: J.E. Flynn Capital, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD PRIVATE DESIGN FUND V, L.P.

     

    By: Deerfield Mgmt V, L.P., General Partner

     

    By: J.E. Flynn Capital V, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    JAMES E. FLYNN

     

    /s/ Jonathan Isler

    Jonathan Isler, Attorney-In-Fact

     

    Date: August 2, 2021

     

     

    Exhibit List

     

    Exhibit A. Joint Filing Agreement.

     

    Exhibit B. Item 8 Statement.

     

    Exhibit C. Power of Attorney.

     

     

    Exhibit A

     

    Joint Filing Agreement

     

    The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Common Stock of Sema4 Holding Corp. shall be filed on behalf of the undersigned.

     

     

    DEERFIELD MGMT, L.P.

     

    By: J.E. Flynn Capital, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD MANAGEMENT COMPANY, L.P.

     

    By: Flynn Management LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD MGMT V, L.P.

     

    By: J.E. Flynn Capital V, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD PARTNERS, L.P.

     

    By: Deerfield Mgmt, L.P., General Partner

     

    By: J.E. Flynn Capital, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    DEERFIELD PRIVATE DESIGN FUND V, L.P.

     

    By: Deerfield Mgmt V, L.P., General Partner

     

    By: J.E. Flynn Capital V, LLC, General Partner

     

    By: /s/ Jonathan Isler

           Jonathan Isler, Attorney-In-Fact

     

     

    JAMES E. FLYNN

     

    /s/ Jonathan Isler

    Jonathan Isler, Attorney-In-Fact

     

     

    Exhibit B

     

    Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

     

     

    Exhibit C

     

    POWER OF ATTORNEY

     

    Know all by these presents, each of the undersigned hereby constitutes and appoints each of Jonathan Isler, and David J. Clark, each signing singly, the undersigned’s true and lawful attorney-in-fact to:

     

    (1)execute for and on behalf of the undersigned (i) Forms 3, 4 and 5 (and all amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder and (ii) reports on Schedule 13G and Schedule 13D (and all amendments thereto)  in accordance with Section 13 of the Exchange Act and the rules thereunder, in each case with respect to the beneficial ownership of securities by the undersigned;

     

    (2)do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 or Schedule 13G or Schedule 13D, complete and execute any amendment or amendments thereto, and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

     

    (3)take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

     

    The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 13 or Section 16 of the Exchange Act.

     

    This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

      

     

    IN WITNESS WHEREOF, each of the undersigned has caused this Power of Attorney to be executed as of this 2nd day of August, 2021.

     

    DEERFIELD MGMT, L.P.
       
    By:    J.E. Flynn Capital, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD PARTNERS, L.P.
       
    By: Deerfield Mgmt, L.P., General Partner
       
    By: J.E. Flynn Capital, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.
       
    By: Deerfield Mgmt, L.P., General Partner
       
    By: J.E. Flynn Capital, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD PDI FINANCING II, L.P.
       
    By: Deerfield Mgmt, L.P., General Partner
       
    By: J.E. Flynn Capital, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD PRIVATE DESIGN FUND II, L.P.
       
    By: Deerfield Mgmt, L.P., General Partner
       
    By: J.E. Flynn Capital, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.
       
    By: Deerfield Mgmt, L.P., General Partner
       
    By: J.E. Flynn Capital, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD MANAGEMENT COMPANY, L.P.
       
    By: Flynn Management LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

      

    DEERFIELD PRIVATE DESIGN FUND III, L.P.
       
    By: Deerfield Mgmt III, L.P., General Partner
       
    By: J.E. Flynn Capital III, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD MGMT III, L.P.
       
    By: J.E. Flynn Capital III, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

      

     

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.      
       
    By: Deerfield Mgmt HIF, L.P., General Partner
       
    By: J.E. Flynn Capital HIF LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD MGMT IV, L.P.

       
    By: J.E. Flynn Capital IV, LLC, General Partner
       
    By: /s/ James E. Flynn
     

    James E. Flynn, President

     

     

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

         
    By: Deerfield Mgmt HIF, L.P., General Partner  
         
    By: J.E. Flynn Capital HIF LLC, General Partner  
         
    By: /s/ James E. Flynn  
      James E. Flynn, President  

     

     

    DEERFIELD MGMT HIF, L.P.

     

    By: J.E. Flynn Capital HIF LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

     

    BREAKING STICK HOLDINGS, LLC

     

    By: Deerfield Management Company, L.P., Manager

     

    By: Flynn Management LLC, General Partner

     

    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD PRIVATE DESIGN FUND V, L.P.

       
    By: Deerfield Mgmt V, L.P., General Partner
       
    By: J.E. Flynn Capital V, LLC, General Partner
       
    By: /s/ James E. Flynn
      James E. Flynn, President

     

     

    DEERFIELD MGMT V, L.P.

       
    By: J.E. Flynn Capital V, LLC, General Partner
       
    By: /s/ James E. Flynn
     

    James E. Flynn, President 

     

     

    DEERFIELD HEALTHCARE INNOVATIONS FUND II, L.P.
       
    Deerfield Mgmt HIF II, L.P., General Partner  
       
    J.E. Flynn Capital HIF II LLC, General Partner  
       
    /s/ James E. Flynn  
    James E. Flynn, President  

     

     

    JAMES E. FLYNN

     

    /s/ James E. Flynn

     

     

     

     

     

    Get the next $CMLF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CMLF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMLF
    Leadership Updates

    Live Leadership Updates

    See more
    • Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

      Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of Andrew Kasarskis, PhD, to the newly established role of Chief Data Officer (CDO). Dr. Kasarskis brings more than 20 years of leadership and broad experience in industry and academia that includes a strong focus on digital analytics and genomics and internationally recognized research in the life sciences. At Sema4, he will be responsible for establishing additional structures and processes to further optimize the company's health intelligence platform and orchestrating data use and data science to support research, development, and innov

      6/17/21 7:00:00 AM ET
      $CMLF
      Business Services
      Finance

    $CMLF
    SEC Filings

    See more
    • SEC Form 424B3 filed by CM Life Sciences, Inc.

      424B3 - Sema4 Holdings Corp. (0001818331) (Filer)

      10/14/21 9:58:15 PM ET
      $CMLF
      Business Services
      Finance
    • CM Life Sciences, Inc. filed SEC Form 8-K: Leadership Update

      8-K - Sema4 Holdings Corp. (0001818331) (Filer)

      10/14/21 5:23:09 PM ET
      $CMLF
      Business Services
      Finance
    • SEC Form S-8 filed by CM Life Sciences, Inc.

      S-8 - Sema4 Holdings Corp. (0001818331) (Filer)

      9/27/21 4:46:23 PM ET
      $CMLF
      Business Services
      Finance

    $CMLF
    Financials

    Live finance-specific insights

    See more
    • Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

      37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue (excluding COVID-19 tests) compared to the same period last year Reiterating full year 2022 total revenue guidance of $215-225 million Sema4 to host conference call today at 4:30 p.m. ET STAMFORD, Conn., March 14, 2022 (GLOBE NEWSWIRE) -- Sema4 Holdings Corp. (NASDAQ:SMFR) ("Sema4"), an AI-driven genomic and clinical data intelligence platform company, today reported its financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on key strategic and ope

      3/14/22 4:05:00 PM ET
      $CMLF
      $SMFR
      Business Services
      Finance
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CMLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Sherman Rachel E.

      4 - Sema4 Holdings Corp. (0001818331) (Issuer)

      10/19/21 7:31:01 PM ET
      $CMLF
      Business Services
      Finance
    • SEC Form 4 filed by Turner Nat

      4 - Sema4 Holdings Corp. (0001818331) (Issuer)

      10/19/21 7:29:25 PM ET
      $CMLF
      Business Services
      Finance
    • SEC Form 4 filed by Pellini Michael J

      4 - Sema4 Holdings Corp. (0001818331) (Issuer)

      10/19/21 7:27:37 PM ET
      $CMLF
      Business Services
      Finance

    $CMLF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

      37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue (excluding COVID-19 tests) compared to the same period last year Reiterating full year 2022 total revenue guidance of $215-225 million Sema4 to host conference call today at 4:30 p.m. ET STAMFORD, Conn., March 14, 2022 (GLOBE NEWSWIRE) -- Sema4 Holdings Corp. (NASDAQ:SMFR) ("Sema4"), an AI-driven genomic and clinical data intelligence platform company, today reported its financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on key strategic and ope

      3/14/22 4:05:00 PM ET
      $CMLF
      $SMFR
      Business Services
      Finance
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company

      Sema4 Holdings Corp ("Sema4") to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human healthBusiness combination expected to result in ~$500 million in cash proceeds to Sema4 to accelerate organic and inorganic growthCombined company to trade on Nasdaq under ticker "SMFR" STAMFORD, Conn., July 22, 2021 (GLOBE NEWSWIRE) -- Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the completion of its business combination with CM Life

      7/22/21 9:15:41 AM ET
      $TWST
      $MGTA
      $CMLF
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Business Services
    • Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

      Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4's Board of Directors upon his official appointment after Sema4 closes its previously announced business combination with CM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210707005228/en/Jason Ryan (Photo: Business Wire) Mr. Ryan most recently served as Chief Operating and Financial Officer of Magenta Therapeutics (NA

      7/7/21 7:00:00 AM ET
      $TWST
      $CMLF
      $MGTA
      $OMIC
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Business Services
      Finance

    $CMLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by CM Life Sciences, Inc.

      SC 13D - Sema4 Holdings Corp. (0001818331) (Subject)

      10/13/21 2:31:34 PM ET
      $CMLF
      Business Services
      Finance
    • SEC Form SC 13D filed by CM Life Sciences, Inc.

      SC 13D - Sema4 Holdings Corp. (0001818331) (Subject)

      8/30/21 4:45:58 PM ET
      $CMLF
      Business Services
      Finance
    • SEC Form SC 13D filed by CM Life Sciences, Inc.

      SC 13D - Sema4 Holdings Corp. (0001818331) (Subject)

      8/2/21 4:59:57 PM ET
      $CMLF
      Business Services
      Finance